High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients — Stella

Recruiting

Back to West Nile Fever trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Israel

Sheba Medical Center, Ramat Gan

Key details

Phase

Safety & dosing

Sponsor

Gili Regev-Yochay MD

Enrollment target

~37 participants

Started

July 2025

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov